131 related articles for article (PubMed ID: 33242138)
1. The course of lung oligometastatic colorectal cancer may be a reflection of selection for treatment rather than an effect of stereotactic body radiotherapy.
Macbeth F; Treasure T
Strahlenther Onkol; 2021 Jan; 197(1):74-75. PubMed ID: 33242138
[No Abstract] [Full Text] [Related]
2. Reply to: The course of lung oligometastatic colorectal cancer may be a reflection of selection for treatment rather than an effect of stereotactic body radiotherapy.
Nicosia L; Cuccia F; Alongi F
Strahlenther Onkol; 2021 Jan; 197(1):76-78. PubMed ID: 33242139
[No Abstract] [Full Text] [Related]
3. Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy.
Nicosia L; Cuccia F; Mazzola R; Ricchetti F; Figlia V; Giaj-Levra N; Rigo M; Tomasini D; Pasinetti N; Corradini S; Ruggieri R; Alongi F
Strahlenther Onkol; 2020 Sep; 196(9):813-820. PubMed ID: 32399637
[TBL] [Abstract][Full Text] [Related]
4. Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up.
Agolli L; Bracci S; Nicosia L; Valeriani M; De Sanctis V; Osti MF
Clin Colorectal Cancer; 2017 Mar; 16(1):58-64. PubMed ID: 27522627
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiotherapy for oligometastatic lung tumors.
Norihisa Y; Nagata Y; Takayama K; Matsuo Y; Sakamoto T; Sakamoto M; Mizowaki T; Yano S; Hiraoka M
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):398-403. PubMed ID: 18374506
[TBL] [Abstract][Full Text] [Related]
7. Exploratory Analysis on Overall Survival after Either Surgery or Stereotactic Radiotherapy for Lung Oligometastases from Colorectal Cancer.
Filippi AR; Guerrera F; Badellino S; Ceccarelli M; Castiglione A; Guarneri A; Spadi R; Racca P; Ciccone G; Ricardi U; Ruffini E
Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):505-12. PubMed ID: 26899780
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer.
Shultz DB; Filippi AR; Thariat J; Mornex F; Loo BW; Ricardi U
J Thorac Oncol; 2014 Oct; 9(10):1426-33. PubMed ID: 25170641
[TBL] [Abstract][Full Text] [Related]
9. [Oligometastatic disease, a new concept: stereotactic irradiation for lung metastases. Literature review].
Hatime M; Elmorabit B; Elkhoti Y; Touch S; Tanguy R; Mornex F
Cancer Radiother; 2012 Sep; 16(5-6):351-7. PubMed ID: 22921980
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer.
Abbas G; Danish A; Krasna MJ
Surg Oncol Clin N Am; 2016 Jul; 25(3):553-66. PubMed ID: 27261915
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic radiosurgery for early stage non-small cell lung cancer: rationale, patient selection, results, and complications.
Christie NA; Pennathur A; Burton SA; Luketich JD
Semin Thorac Cardiovasc Surg; 2008; 20(4):290-7. PubMed ID: 19251167
[TBL] [Abstract][Full Text] [Related]
12. Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy.
Milano MT; Katz AW; Schell MC; Philip A; Okunieff P
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1516-22. PubMed ID: 18495378
[TBL] [Abstract][Full Text] [Related]
13. A radiation oncologist's and thoracic surgeon's view on the role of stereotactic ablative radiotherapy for operable lung cancer.
Timmerman RD; Fernando HC
Semin Thorac Cardiovasc Surg; 2013; 25(1):8-13. PubMed ID: 23800524
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of stereotactic ablative radiotherapy for lung metastases arising from colorectal cancer.
Jung J; Song SY; Kim JH; Yu CS; Kim JC; Kim TW; Jeong SY; Kim SS; Choi EK
Radiat Oncol; 2015 Nov; 10():238. PubMed ID: 26588896
[TBL] [Abstract][Full Text] [Related]
15. [Stereotactic body radiation radiotherapy for oligometastatic non-small cell lung cancer (NSCLC): A case report].
Leduc C; Antoni D; Quoix É; Noël G
Cancer Radiother; 2015 May; 19(3):192-7. PubMed ID: 25841992
[TBL] [Abstract][Full Text] [Related]
16. Ablative stereotactic radiotherapy for oligometastatic colorectal cancer: Systematic review.
Kobiela J; Spychalski P; Marvaso G; Ciardo D; Dell'Acqua V; Kraja F; Błażyńska-Spychalska A; Łachiński AJ; Surgo A; Glynne-Jones R; Jereczek-Fossa BA
Crit Rev Oncol Hematol; 2018 Sep; 129():91-101. PubMed ID: 30097241
[TBL] [Abstract][Full Text] [Related]
17. A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).
Radwan N; Phillips R; Ross A; Rowe SP; Gorin MA; Antonarakis ES; Deville C; Greco S; Denmeade S; Paller C; Song DY; Diehn M; Wang H; Carducci M; Pienta KJ; Pomper MG; DeWeese TL; Dicker A; Eisenberger M; Tran PT
BMC Cancer; 2017 Jun; 17(1):453. PubMed ID: 28662647
[TBL] [Abstract][Full Text] [Related]
18. [Stereotactic ablative irradiation for lung cancer].
Antoni D; Srour I; Noël G; Mornex F
Cancer Radiother; 2014; 18(4):297-307. PubMed ID: 24907006
[TBL] [Abstract][Full Text] [Related]
19. To SABR or not to SABR? Indications and contraindications for stereotactic ablative radiotherapy in the treatment of early-stage, oligometastatic, or oligoprogressive non-small cell lung cancer.
Shultz DB; Diehn M; Loo BW
Semin Radiat Oncol; 2015 Apr; 25(2):78-86. PubMed ID: 25771411
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic ablative body radiotherapy for lung cancer.
Franks KN; Jain P; Snee MP
Clin Oncol (R Coll Radiol); 2015 May; 27(5):280-9. PubMed ID: 25746732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]